title: Contrast-enhanced cardiac magnetic resonance in a patient with chemotoxic cardiomyopathy.
abstract: Gadolinium-enhanced cardiac magnetic resonance was performed in a patient with chemotoxic cardiomyopathy. Intramyocardial midwall linear delayed hyperenhancement was found. Such a finding is consistent with midwall fibrosis and/or myocardial cell loss due to cardiotoxic effect of chemotherapy.
authors.affiliation: Division of Cardiology, IRCCS Salvatore Maugeri Foundation, Pavia, Italy. ocatalano@fsm.it
authors.forename: Oronzo
authors.initials: O
authors.lastname: Catalano
authors.forename: Serena
authors.initials: S
authors.lastname: Antonaci
authors.forename: Guido
authors.initials: G
authors.lastname: Moro
authors.forename: Maurizia
authors.initials: M
authors.lastname: Baldi
authors.forename: Franco
authors.initials: F
authors.lastname: Cobelli
authors.forename: Cristina
authors.initials: C
authors.lastname: Opasich
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000503:physiopathology; D003287:Contrast Media; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D006801:Humans; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods; D008297:Male; D013318:Stroke Volume; D014750:Vincristine / Q000009:adverse effects
chemical_list: D003287:Contrast Media; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide